Liver enzymes and incident diabetes

Diabetes Care

Volumn 31, Issue 6, 2008, Pages 1138-1143

  Ford, Earl S ^a   Schulze, Matthias B ^b   Bergmann, Manuela M ^b   Thamer, Claus ^c   Joost, Hans Georg ^b   Boeing, Heiner ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BLOOD LEVEL; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; BLOOD; ENZYMOLOGY; GERMANY; INCIDENCE; LIFESTYLE; LIVER; MIDDLE AGED; PREDICTION AND FORECASTING; QUESTIONNAIRE;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; DIABETES MELLITUS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GERMANY; HUMANS; INCIDENCE; LIFE STYLE; LIVER; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES;

EID: 48649094475     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2159     Document Type: Article

References (26)

1. Perry IJ, Wannamethee SG, Shaper AG: Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 21:732-737, 1998
2. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA: High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:1889-1895, 2002
3. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr: Gamma-glutamyltransferase and diabetes: 4 yr follow-up. Diabetologia 46: 359-364, 2003
4. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358-1366, 2003
5. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K: Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 254:287-295, 2003
6. Nakanishi N, Suzuki K, Tatara K: Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 in middle-aged Japanese men. Diabetes Care 27: 1427-1432, 2004
7. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM: Insulin resistance atherosclerosis study: elevations in markers of liver injury and risk of type 2: the Insulin Resistance Atherosclerosis Study. Diabetes 53:2623-2632, 2004
8. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J: Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 89: 5410-5414, 2004
9. Wannamethee SG, Shaper AG, Lennon L, Whincup PH: Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28: 2913-2918, 2005
10. Meisinger C, Lowel H, Heier M, Schneider A, Thorand B, KORA Study Group: Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 258:527-535, 2005
11. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E, Mexico City Diabetes Study: Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28:1757-1762, 2005
12. Andre P, Balkau B, Born C, Charles MA, Eschwege E, D.E.S.I.R. Study Group: Three-year increase of gamma-glutamyl-transferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 49: 2599-2603, 2006
13. Takahashi K, Uchiyama H, Yanagisawa S, Kamae I: Logistic regression and ROC analysis of group-based screening for predicting incidence in 4 yrs. Kobe J Med Sci 52:171-180, 2006
14. Ohlson LO, Larsson B, Bjorntorp P, Eriksson H, Svardsudd K, Welin L, Tibblin G, Wilhelmsen L: Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31:798 -805, 1988
15. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J, West of Scotland Coronary Prevention Study: Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 53:2855-2860, 2004
16. Schindhelm RK, Dekker JM, Nijpels G, Heine RJ, Diamant M: No independent association of alanine aminotransferase with risk of future type 2 in Hoorn study. Diabetes Care 28:2812, 2005
17. Loguercio C, De Simone T, D'Auria MV, de Sio I, Federico A, Tuccillo C, Abbatecola AM, Del Vecchio Blanco C, Italian AISF Clinical Group: Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig Liver Dis 36:398-405, 2004
18. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850, 2001
19. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-3253, 2004
20. Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816 -823, 2004
21. Lee DH, Blomhoff R, Jacobs DR Jr: Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535-539, 2004
22. Boeing H, Wahrendorf J, Becker N: EPIC-Germany: a source for studies into diet and risk of chronic diseases: European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:195-204, 1999
23. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, He- mon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113-1124, 2002
24. Boeing H, Korfmann A, Bergmann MM: Recruitment procedures of EPIC-Germany: European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:205-215, 1999
25. Lee Goldman L, Ausiello D (Eds.): Cecil Textbook of Medicine. 22nd ed. Philadelphia, PA, Saunders, An Imprint of Elsevier, 2004
26. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G: Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-10, 2002